Skip to content

Early Feasibility Data Collection using ClearSight on Children Less than Two Years Old.

Early Feasibility Data Collection using ClearSight on Children Less than Two Years Old. - ClearSight Baby Cuff

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56297
Enrollment
15
Registered
2023-11-16
Start date
2024-01-10
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A, measurement of blood pressure with a finger cuff n/a Non invasive blood pressure monitoring

Interventions

None listed

Sponsors

Edwards Lifesciences LLC
Lead Sponsor

Eligibility

Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Children in the age 0-2 years during anesthesia for a planned surgery

Exclusion criteria

Exclusion criteria: 1. Any significant disfigurement or prior injury to a participant*s finger that is intended to be used for monitoring with the prototype finger cuff 2. Inability to place finger cuffs appropriately due to subject anatomy, condition, or obstructive paraphernalia 3. Known sensitivities to system materials 4. Broken or open skin located at the site of the finger cuff 5. Proven left*right difference in blood pressure 6. Cardiac problems that can cause a difference in blood pressure between the two arms, including aortic coarctation 7. Extreme contraction of the smooth muscles in the arteries and arterioles of the lower arm and hand, such as may be present in patients with Raynaud*s disease

Design outcomes

Primary

MeasureTime frame
As the study is an early feasibility data collection, the primary outcome of the study is the confirmation that the design works and is able to measure blood pressure continously and non-invasively in children 0-2 years old. Measurement accuracy is determined by comparing the ClearSight blood pressure reading to a standard blood pressure reading.

Secondary

MeasureTime frame
Aspects such as ease of use will also be evaluated

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)